Cargando…
Development of Pluoronic nanoparticles of fluorocoxib A for endoscopic fluorescence imaging of colonic adenomas
SIGNIFICANCE: Current white light colonoscopy suffers from many limitations that allow 22% to 32% of preneoplastic lesions to remain undetected. This high number of false negatives contributes to the appearance of interval malignancies, defined as neoplasms diagnosed between screening colonoscopies...
Autores principales: | Uddin, Md. Jashim, Niitsu, Hiroaki, Coffey, Robert J., Marnett, Lawrence J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Photo-Optical Instrumentation Engineers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118138/ https://www.ncbi.nlm.nih.gov/pubmed/37091910 http://dx.doi.org/10.1117/1.JBO.28.4.040501 |
Ejemplares similares
-
Detection of carcinogen-induced bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019) -
Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A
por: Ra, Hyejun, et al.
Publicado: (2015) -
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019) -
Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer
por: Cekanova, Maria, et al.
Publicado: (2020) -
Fluorescence signatures of SARS-CoV-2 spike S1 proteins and a human ACE-2: excitation-emission maps and fluorescence lifetimes
por: Grzesiak, Jonas, et al.
Publicado: (2022)